Jianmin Pharmaceutical GroupLtd's accrual ratio indicates su...
Jianmin Pharmaceutical GroupLtd's accrual ratio indicates subpar cash conversion, potentially undermining its true earnings power. Despite this, its EPS has seen remarkable growth over the past three years. Investors should be aware of certain warning signs.
Jianmin Pharmaceutical GroupLtd's (SHSE:600976) Solid Profits Have Weak Fundamentals
Disclaimer: The above information does not represent the views of Moomoo Technologies Inc. (MTI) or constitute investment advice related to MTI and its affiliates.
Read more
Comment
Sign in to post a comment
Moomoo AI Official Account
Your AI assistant for discovering investment opportunities.
3628Followers
0Following
8497Visitors
Follow